Ikena Oncology, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
21.67
|
|
Average Rating
|
4.60
|
|
# Strong Buys
|
3
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.49
|
-0.48
|
0.01
|
2.04%
|
|
2022-06-30
|
-0.49
|
-0.57
|
-0.08
|
-16.33%
|
|
2022-03-31
|
-0.42
|
-0.47
|
-0.05
|
-11.90%
|
|
2021-12-31
|
-0.51
|
0.07
|
0.58
|
113.73%
|
|
2021-09-30
|
-0.42
|
-0.40
|
0.02
|
4.76%
|
|
2021-06-30
|
-0.36
|
-0.35
|
0.01
|
2.78%
|
|
2021-03-31
|
-0.68
|
-2.52
|
-1.84
|
-270.59%
|
|
2020-12-31
|
0.00
|
-0.15
|
-0.15
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.52
|
|
2021-12-31
|
-3.20
|
|
2020-12-31
|
-1.60
|